Delivery Order SPE2DB22D2006-SPE2DB25FW2UL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,019.89 to AmerisourceBergen Drug Corp for Meclizine 25 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,143,775 units of the medication meclizine 25 mg tablets. The delivery order has a ceiling value of $1,737.10 and is a firm fixed-price contract. The place of performance is Conshohocken, Pennsylvania. The award date is May 5, 2025, and the ultimate completion date is May 6, 2025. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $1,094.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,988,577 units of Meclizine 25 mg tablets. This appears to be a delivery order contract with a firm fixed price pricing structure. The award has an ultimate completion date of January 20, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $25,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 25mg meclizine tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility in performance spanning August 17-18, 2023. The DLA utilizes indefinite-delivery/indefinite-quantity contracts to support various medical commodity requirements for the Department of Defense. No set aside designation or...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,105.96 for metoclopramide 10mg tablets (25-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Mefloquine HCl 250 mg tablets in unit dose packaging (25-count) with a contract value of $1,375.49. This competitively awarded, non-set-aside delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries a firm fixed price structure. The awarded vendor, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $23,599.21 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in medical settings. This firm fixed price delivery order, awarded on July 24, 2025, with completion targeted for July 25, 2025, represents a child order issued under a larger contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count supply) with a ceiling value of $2,320.65. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mefloquine HCL 250 mg tablets in unit dose packaging of 25 tablets. This is a firm fixed-price delivery order with a ceiling value of $1,813.75 and a completion date of July 28, 2025. The award was made competitively with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $8,001.71. This is a firm fixed price, non-competitive delivery order executed under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2ULDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 tablets of Meclizine 25 mg, a medication commonly used to treat nausea and vertigo. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $2,506.47 and an ultimate completion date of July 25, 2025. The place of performance is AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/24/25 |